Why Zepp Health Corporation’s (ZEPP) Stock Is Down 5.44%

By Jenna Brashear
June 02, 2026
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Zepp Health Corporation before investing.

In this article, we go over a few key elements for understanding Zepp Health Corporation’s stock price such as:

  • Zepp Health Corporation’s current stock price and volume
  • Why Zepp Health Corporation’s stock price changed recently
  • Upgrades and downgrades for ZEPP from analysts
  • ZEPP’s stock price momentum as measured by its relative strength

About Zepp Health Corporation (ZEPP)

Before we jump into Zepp Health Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company offers smart bands, smart watches, smart rings, hearables, the Helio Strap, smart scales, and accessories; and sportswear, home appliances, and smart watch accessories. It also provides Zepp Aura, a real-time, personalized sound health solution offering health management, including emotional regulation and sports performance optimization; and provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company offers its products under the Amazfit and Zepp brand names in approximately 90 countries. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is based in Gorinchem, The Netherlands.

Want to learn more about Zepp Health Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Zepp Health Corporation.

Learn More About A+ Investor

Zepp Health Corporation’s Stock Price as of Market Close

As of June 02, 2026, 12:42 PM, CST, Zepp Health Corporation’s stock price was $7.500.

Zepp Health Corporation is up 0.67% from its previous closing price of $7.450.

During the last market session, Zepp Health Corporation’s stock traded between $7.270 and $8.260. Currently, there are approximately 15.88 million shares outstanding for Zepp Health Corporation.

Zepp Health Corporation’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Zepp Health Corporation Stock Price History

Zepp Health Corporation’s (ZEPP) price is currently down 8.09% so far this month.

During the month of June, Zepp Health Corporation’s stock price has reached a high of $8.500 and a low of $7.270.

Over the last year, Zepp Health Corporation has hit prices as high as $61.850 and as low as $2.250. Year to date, Zepp Health Corporation’s stock is down 72.16%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Zepp Health Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of June 01, 2026, there were analysts who downgraded Zepp Health Corporation’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Zepp Health Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Zepp Health Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Zepp Health Corporation’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Zepp Health Corporation (ZEPP) by visiting AAII Stock Evaluator.

Relative Price Strength of Zepp Health Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of June 01, 2026, Zepp Health Corporation has a weighted four-quarter relative price strength of 263.80%, which translates to a Momentum Score of 100 and is considered to be Very Strong.

Want to learn more about how Zepp Health Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Zepp Health Corporation Stock Price: Bottom Line

As of June 2, 2026, Zepp Health Corporation’s stock price is $7.500, which is up 0.67% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Zepp Health Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Neil CAN SLIM Screen: 38.3% Compared to S&P 500
at only 23.3%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.